Nutrients: Magnesium, B12, L-Carnitine, Taurine, Glutamine and Proline Frequency: Weekly to monthly Benefits: Reduce fatigue and support muscle endurance, allowing you to train harder and bounce back faster
Improves energy levels, mental clarity and mood Effective in reducing cravings and improving post-workout recovery Compounded & made-to-order by a U.S

The market is being reshaped by 6 forces: Market size: $94B today $216B+ by 2035 (8.8% CAGR) Oral GLP-1s just got FDA approval eliminating the needle barrier for millions WHO officially recommends GLP-1s for long-term obesity treatment (Dec 2025) Novo Nordisk slashed Ozempic/Wegovy prices by up to 70% unlocking mass adoption Next-gen tri-agonists (retatrutide) showing 28.7% weight loss in trials Only ~7% diabetes penetration and ~2% obesity penetration the growth runway is massive The ripple effects extend far beyond pharma: Food & beverage: $30$55B annual revenue at risk as GLP-1 users cut calories by 21% Employers: 77% of large companies say managing GLP-1 costs is a top priority Eli Lilly became the first pharma company to surpass $1 trillion market cap ~150 GLP-1 drugs now in development globally 2530 million Americans projected on GLP-1 therapy by 2030 The question isnt whether GLP-1s will reshape global healthcare

PDGF : Marketed as a next-generation treatment at Florida med spas, Platelet-Derived Growth Factor injectables mimic the growth factor found in humans but are manufactured in a lab
Epstein LJ, Kristo D, Strollo PJ, et al